AG
TMDX icon

Algert Global’s Transmedics TMDX Stock Holding History

Algert Global’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.53M Sell
25,444
-4,850
-16% -$633K 0.04% 653
2025
Q4 		$3.69M Buy
30,294
+3,370
+13% +$423K 0.06% 541
2025
Q3 		$3.02M Buy
26,924
+13,740
+104% +$1.61M 0.05% 560
2025
Q2 		$1.77M Sell
13,184
-490
-4% -$53.8K 0.04% 667
2025
Q1 		$920K Buy
13,674
+1,120
+9% +$77K 0.02% 785
2024
Q4 		$783K Sell
12,554
-26,494
-68% -$2.47M 0.02% 836
2024
Q3 		$6.13M Buy
39,048
+21,223
+119% +$3.27M 0.16% 182
2024
Q2 		$2.69M Buy
+17,825
New +$2.14M 0.09% 369
2024
Q1 		– Sell
-4,830
Closed -$381K – 1276
2023
Q4 		$381K Buy
+4,830
New +$291K 0.02% 890
2023
Q3 		– Sell
-38,974
Closed -$3.27M – 1254
2023
Q2 		$3.27M Buy
38,974
+21,919
+129% +$1.68M 0.14% 221
2023
Q1 		$1.29M Buy
17,055
+9,074
+114% +$628K 0.06% 531
2022
Q4 		$493K Buy
7,981
+1,740
+28% +$92.5K 0.03% 807
2022
Q3 		$260K Buy
+6,241
New +$271K 0.02% 979

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Algert Global's TMDX Position: Q1 2026 in Review

Algert Global reduced its Transmedics (TMDX) stake by 16% in Q1 2026, selling an estimated $633K and leaving 25,444 shares worth $2.53M. The position accounts for 0.04% of the portfolio, ranked #653.

Algert Global first reported a position in TMDX in Q3 2022 and has held it in 13 quarters since. The position peaked at $6.13M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Algert Global held 25,444 shares of Transmedics worth $2.53M as of Q1 2026.
  • Algert Global sold 4,850 Transmedics shares in Q1 2026, an estimated $633K.
  • Transmedics made up 0.04% of Algert Global's portfolio in Q1 2026, its #653 holding.
  • Algert Global first reported a position in Transmedics in Q3 2022 and has held it in 13 quarters since.
  • Algert Global's Transmedics position peaked at $6.13M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.